Editor's Correspondence |

Lack of Positive Correlation Between Statin Use and Bone Mineral Density in Japanese Subjects With Type 2 Diabetes—Reply

Yoshiharu Wada, MD; Yoshio Nakamura, MD, PhD; Hiroyuki Koshiyama, MD, PhD
Arch Intern Med. 2000;160(18):2865. doi:.
Text Size: A A A
Published online


Recently Mundy et al1 have indicated that some statins, 3-hydroxy-3-methylglutaryl coenzyme A (HMG Co-A) reductase inhibitors in particular, have a potent stimulatory effect on bone formation in vitro and in experimental animals, possibly through increased expression of the bone morphogenetic protein 2 (BMP2) gene. Since the dosages of the statins in the study were much larger than would be used clinically, the significance of their stimulatory action in bone formation remains to be elucidated in humans. We investigated the relationship between statin use and lumbar bone mineral density (BMD) in a total of 440 Japanese subjects with type 2 diabetes (214 men and 226 women; mean [SE] age, 61.7 [0.9] years). Lumbar BMD was measured with dual-energy x-ray absorptiometry (QDR-4500; Hologic Co, Waltham, Mass), as previously described.2,3 Statins were used in 131 subjects: pravastatin in 88.5%, simvastatin in 9.2%, and fluvastatin in 2.3%. Surprisingly, the mean (SE) BMD was significantly lower in subjects receiving statins than in those not receiving statins (0.884 [0.15] vs 0.965 [0.11] g/cm2, P<.001). Furthermore, there was a negative correlation between BMD and the total serum cholesterol level in type 2 diabetes (r = 0.254, P<.001).

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles

Users' Guides to the Medical Literature
Clinical Scenario

Users' Guides to the Medical Literature
Statin Dosing and LDL Levels